Source: Nutrition. Unidade: FCF
Subjects: PROBIÓTICOS, ARTERIOSCLEROSE, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANNA, Adriélly F et al. Chronic administration of the soluble, nonbacterial fraction of kefir attenuates lipid deposition in LDLr-/- mice. Nutrition, v. 35, p. 100-105, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.nut.2016.11.001. Acesso em: 17 out. 2024.APA
Santanna, A. F., Filete, P. F., Lima, E. M., Porto, M. L., Meyrelles, S. S., Vasquez, E. C., et al. (2017). Chronic administration of the soluble, nonbacterial fraction of kefir attenuates lipid deposition in LDLr-/- mice. Nutrition, 35, 100-105. doi:10.1016/j.nut.2016.11.001NLM
Santanna AF, Filete PF, Lima EM, Porto ML, Meyrelles SS, Vasquez EC, Endringer DC, Lenz D, Abdalla DSP, Pereira TMC, Andrade TU de. Chronic administration of the soluble, nonbacterial fraction of kefir attenuates lipid deposition in LDLr-/- mice [Internet]. Nutrition. 2017 ; 35 100-105.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.nut.2016.11.001Vancouver
Santanna AF, Filete PF, Lima EM, Porto ML, Meyrelles SS, Vasquez EC, Endringer DC, Lenz D, Abdalla DSP, Pereira TMC, Andrade TU de. Chronic administration of the soluble, nonbacterial fraction of kefir attenuates lipid deposition in LDLr-/- mice [Internet]. Nutrition. 2017 ; 35 100-105.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.nut.2016.11.001